Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) EBT: 2020-2023

Historic EBT for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to -$54.8 million.

  • Immuneering's EBT fell 15.44% to -$15.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$54.8 million, marking a year-over-year decrease of 8.03%. This contributed to the annual value of -$54.8 million for FY2023, which is 8.50% down from last year.
  • According to the latest figures from FY2023, Immuneering's EBT is -$54.8 million, which was down 8.50% from -$50.5 million recorded in FY2022.
  • Immuneering's 5-year EBT high stood at -$17.0 million for FY2020, and its period low was -$54.8 million during FY2023.
  • Its 3-year average for EBT is -$46.4 million, with a median of -$50.5 million in 2022.
  • Data for Immuneering's EBT shows a maximum YoY slumped of 98.61% (in 2021) over the last 5 years.
  • Over the past 4 years, Immuneering's EBT (Yearly) stood at -$17.0 million in 2020, then slumped by 98.61% to -$33.8 million in 2021, then tumbled by 49.26% to -$50.5 million in 2022, then declined by 8.50% to -$54.8 million in 2023.